Acquired OTC Wellness Business Q1 net sales $51.7M, net income $12.6M

Prestige Consumer Healthcare Inc.

Net sales of $51.7M for Q1 2026, up 2.4% from $50.5M in Q1 2025.
Net income of $12.6M, down 14.4% from $14.8M in prior-year quarter.
Intangible assets net of $328.3M and goodwill of $151.5M as of March 31, 2026.
Business includes brands Breathe Right, Dimetapp, Anbesol, Alavert, Primatene, and others.
Pro forma financials for Prestige Consumer Healthcare also filed as part of the acquisition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.